Canada: Les nouveaux Programmes d'immunité et de clémence du Bureau de la concurrence du Canada : compliquer des décisions déjà difficiles

  • Le 27 septembre 2018, le Bureau de la concurrence du Canada (le « Bureau ») a publié la version finale de ses Programmes d'immunité et de clémence en vertu de la Loi sur la concurrence.
  • Les Programmes d'immunité et de clémence (les « Programmes ») prévoient l'octroi de l'immunité (la Couronne s'engage à renoncer à toute poursuite) ou de la clémence (la Couronne recommande au tribunal d'accorder une réduction des sanctions à imposer en échange d'un plaidoyer de culpabilité).

Une traduction de ce billet sera disponible prochainement.

  • On September 27, 2018, Canada's Competition Bureau ("Bureau") released a finalized version of its revised "Immunity and Leniency Programs under the Act".
  • The Immunity and Leniency Programs ("Programs") provide for a grant of immunity (a commitment by the Crown to forego prosecution) or leniency (a recommendation by the Crown to the court for a reduction of the sanctions to be imposed in exchange for a guilty plea).
  • These grants of immunity or leniency are intended as incentives for parties to terminate illegal cartel and bid-rigging conduct, advise the Bureau of the conduct, and thereafter provide full cooperation to the Bureau in its investigation and to the Crown/Director of Public Prosecutions ("DPP") in any prosecution in relation to the illegal conduct.
  • As discussed below, the recent changes to the Programs may respond to concerns within the Bureau and DPP about difficulties in obtaining convictions while at the same time making the decision to enter the Programs more complex and problematic for some potential participants.

BACKGROUND

Since they were formalized in 2000 (Immunity Program) and 2010 (Leniency Program), the Programs have collectively led to multiple guilty pleas in multiple conspiracies and bid-rigging schemes, and tens of millions of dollars in fines in Canada from those participating in criminal anti-competitive conduct under the Competition Act. Nevertheless, and purportedly in response to some high-profile failures to secure price-fixing and bid-rigging convictions, the Bureau concluded that changes to the Programs were needed. Following two rounds of public consultations in October 2017 and May 2018, the Bureau made adjustments in respect of some of the more controversial proposals set out in earlier drafts, but significant concerns remain.

Any potential applicant for credit for cooperation has to do a cost-benefit/risk analysis before seeking immunity or leniency, and the revised Programs give rise to significant issues, which may well lead to a reduction in participation in the Programs.

KEY CHANGES

Many of the changes in the Programs affect both immunity and leniency, as the steps in the processes under both Programs are similar.

Cooperation obligations

The revised Programs set out in some detail the extent of cooperation required both by the corporate immunity or leniency applicant (341) and the directors, officers, employees and agents of the applicant. (35-40)

Grant of interim immunity

One of the principal changes to the Immunity Program is that full immunity (which under the former Program could be revoked in the absence of subsequent cooperation) will now only be provided at the very end of the process. Instead, the revised Immunity Program introduces a grant of interim immunity ("GII"), which provides immunity only on a conditional basis, following which the applicant provides full cooperation — including through the end of any criminal trials of alleged co-conspirators — and only then is final immunity granted. In effect, this adds an additional step to the Canadian immunity process, in which an immunity applicant will:

  1. obtain a marker;
  2. make a proffer;
  3. obtain a GII, which is a "conditional immunity agreement that sets out the applicant's ongoing obligations that must be fulfilled in order for the DPP to finalize the immunity agreement" (74); and
  4. only after all of its cooperation obligations are met, enter an immunity agreement.

An applicant's failure to comply with the obligations set out in the GII may result in the revocation of the interim immunity. The Program states that the applicant will be given notice that the DPP intends to revoke its immunity and given a minimum of 14 days to remedy its failure. (102, 107)

In the Bureau's words, the purpose of adding the GII to the process is to "facilitate the Bureau's investigation by formalizing the legal framework within which an applicant will disclose records and make witnesses available." (73) During the public consultations, concerns were expressed about the risks to an applicant in disclosing all information before knowing that it will be fully protected by a grant of immunity; those concerns are not addressed in the finalized Program. When considering whether to seek immunity in Canada, the absence of complete protection prior to providing full cooperation may well change the cost-benefit analysis for a potential immunity applicant.

Coverage for directors, officers and employees

The revised Programs address coverage for directors, officers and employees ("Individuals") of a corporate immunity or leniency applicant.

Under the revised Immunity Program, a GII may be made available to a business organization or to an individual. (70) Corporate immunity under a GII will extend to all identified current Individuals who:

  • Admit their knowledge of or participation in an offence under the Act as part of the corporate admission; and
  • Cooperate in a "complete, timely and ongoing manner". (79)

The revised Immunity Program specifies that Individuals to be covered under the immunity must be identified by the corporate applicant, and will not be automatically included. Individuals will be covered under the final grant of immunity if they have "upheld the requirements of the Program". (104) Coverage under the Immunity Program for former Individuals or "identified agents" will be "considered for inclusion on a case by case basis." (79) Cooperating Individuals will not automatically lose their immunity in the event that the corporation's immunity is revoked (and vice versa). (108)

Under the Leniency Program, current identified Individuals of the first-in leniency applicant will be immunized from criminal prosecution provided that (as with the Immunity Program) they admit knowledge of or participation in the unlawful conduct and cooperate fully. (145-51) Individuals of subsequent Leniency Program applicants (second-in and subsequent) "may be charged depending on their role in the offence"; in making a recommendation to the DPP regarding the laying of charges or the penalty to be imposed (fine and/or custodial sentence) for Individuals of leniency applicants, "the Bureau will consider all of the available facts and circumstances in respect of such an individual's participation in the offence." (152-53)

Recording of evidence

The Bureau has confirmed that it will continue to permit applicants to use a paperless process when providing proffers. (43) However, under the revised Immunity Program, applicants can expect "that sworn audio-video recorded interviews will be taken at an advanced stage of the investigation in order to support recommendations to the DPP". (92) Under the revised Leniency Program, prior to making a recommendation to the DPP about leniency and the laying of charges against Individuals, the Bureau "ordinarily will seek to schedule and conduct interviews with key witnesses" (in the case of the first-in leniency applicant), and "a key witness" (for the subsequent leniency applicants); those interviews "may be taken under oath and video recorded". (167-70)

During the consultation process, significant concerns were expressed about the potential prejudice to immunity and leniency applicants arising from the making of audio-video recordings, including in the form of discovery demands for production of the recordings in follow-on civil litigation in Canada and elsewhere. The change to refer to "advanced stage" (which is not defined) in the Immunity Program does not address the concerns, and in any event the Leniency Program contemplates interviews very early in the process. These concerns will factor into the cost-benefit analysis for potential immunity and leniency applicants.

Leniency Program credit

The Leniency Program historically has provided for a 50% fine reduction for the first leniency applicant as well as immunity from prosecution for current Individuals, with a fine reduction of 30% for the next in the leniency queue, and unspecified reductions for those coming subsequently. Under the new Leniency Program, every leniency applicant is potentially eligible for a leniency cooperation credit ("LCC") of up to 50% to be applied to the base fine. (139) The amount of the LCC depends on the degree to which the applicant's cooperation enhances the Bureau's investigation and ability to pursue other culpable parties, and takes into account the following factors:

  • Timing of the leniency application (relative to other parties in the cartel, as well as relative to the stage of the Bureau's investigation);2
  • Timeliness of disclosure;
  • Availability, credibility and reliability of witnesses;
  • Relevance and materiality of the applicant's records; and
  • Any other factor relevant to the development of the Bureau's investigation into the matter, or any additional matter for which the party is eligible for "immunity plus."3

These revisions to the Leniency Program give rise to the prospect of "leapfrogging" ahead of other leniency applicants who made the decision to cooperate and self-report more quickly than a subsequent applicant whose cooperation is "better". There is much room for uncertainty of outcome and for negotiation in respect of the LCC to be provided.

Additional credit for corporate compliance programs

In addition to the LCC, which can reduce the fine that an applicant may otherwise face for committing a criminal offence under the Act, the revised Leniency Program provides an additional credit for having a compliance program. Where the Bureau is satisfied that a corporation had a "credible and effective" corporate compliance program in place at the time the offence occurred, when making its recommendation to the DPP the Bureau will treat the compliance program as a mitigating factor resulting in an unspecified reduction of the base fine.4

THE BOTTOM LINE

The decision as to whether a corporation or individual should seek immunity or leniency is always a difficult one, made on imperfect information and subject to time, cost, corporate culture, international consistency and other considerations. The revisions to the Programs may assist the Bureau and the DPP with its investigations and prosecutions, but at the risk of reduced participation in the Programs given the enhanced uncertainty and potential for prejudice arising from the revisions. It may be that the Bureau's reach has exceeded its grasp in making these changes to what have been highly successful programs.

This post has been adapted from a section of our publication "Canadian Competition and Foreign Investment Outlook 2019", which is available here.

Footnotes

[1] Numbers in parentheses refer to paragraphs in the Programs.

[2] The timing of the leniency application is referred to as "an important factor related to cooperation", and may be the one that the Bureau values above the other factors which, by contrast, are referred to as "relevant factors" (see para. 140).

[3] A leniency applicant may be eligible for "immunity plus" status when it discloses evidence of conduct constituting a further criminal offence under the Act unknown to the Bureau. If that leniency applicant meets the requirements set out in the Immunity Program regarding the newly-disclosed offence, the Bureau will recommend that the DPP grant the applicant immunity from prosecution with respect to the newly-disclosed offence (see paras. 141-42).

[4] Mitigating factors apply to both corporations and individuals. The net effect of mitigating factors will be estimated as a percentage of the base fine (see paras. 136-38).

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Mondaq Sign Up
Gain free access to lawyers expertise from more than 250 countries.
 
Email Address
Company Name
Password
Confirm Password
Position
Industry
Mondaq Newsalert
Select Topics
Select Regions
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions